Welcome to our dedicated page for Rocket Lab SEC filings (Ticker: RKLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Rocket Lab's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Rocket Lab's regulatory disclosures and financial reporting.
Rocket Lab Corp (RKLB) reported that Chief Financial Officer Adam C. Spice exercised employee stock options and sold common shares on September 2, 2026. He exercised options for 140,157 shares of common stock at an exercise price of $1.09 per share, then sold the same number of shares in open-market transactions under a Rule 10b5-1 trading plan adopted on June 3, 2026.
The sales comprised 67,257 shares at a weighted-average price of about $62.26 per share within a range of $61.59 to $62.58, and 72,900 shares at a weighted-average price of about $62.97 per share within a range of $62.59 to $63.47. Following the option exercise, Spice held 2,382,668 stock options, and a separate trust associated with him held 250,000 shares of common stock indirectly.
Rocket Lab Corp (RKLB) director Merline Saintil reported a bona fide gift of 261,903 shares of common stock on August 31, 2026, transferring them without consideration to her revocable living trust for estate planning purposes. She now holds 2,482 shares directly and 261,903 shares indirectly through the trust, retaining an indirect pecuniary interest in those trust-held shares. No Rule 10b5-1 trading plan is reported.
Rocket Lab Corp (RKLB) received a Form 144 notice from officer Adam C. Spice indicating an intention to sell up to 140,157 shares of common stock through Morgan Stanley Smith Barney, following an acquisition of these shares via exercise of stock options for cash on September 2, 2026. The securities section lists an aggregate market value of $8,765,418.78 for the shares and cites 598,350,482 shares as a reference outstanding figure. The filing also reports prior sales of Rocket Lab common stock by Spice over the past three months.
Rocket Lab Corp (RKLB) reported that Chief Operations Officer Frank Klein sold a total of 35,558 shares of common stock on August 27, 2026, in three open-market transactions at weighted-average prices of $66.2510, $66.8576, and $67.5387. All sales were made pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2025, and were executed in multiple trades within disclosed price ranges.
Rocket Lab Corp (RKLB) insider Arjun Kampani, SVP & General Counsel, reported selling a total of 6,034 shares of common stock on August 27, 2026 under a Rule 10b5-1 trading plan. The sales were executed in two tranches at weighted-average prices within disclosed intraday ranges.
Rocket Lab Corp (RKLB) received a notice that officer Arjun Kampani intends to sell 6,034 shares of Rocket Lab common stock under Rule 144. The shares, held as restricted stock units, are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate market value of $399,330.12 as of the filing.
The notice also lists prior Rocket Lab share sales by Arjun Kampani during the preceding three months, including 7,754 shares for $539,896.23, 88,000 shares for $9,502,240.00, and 23,804 shares for $3,509,510.40, the last identified as 10b5-1 sales.
Rocket Lab Corp (RKLB) had a notice filed under Rule 144 for a planned sale of its common stock by officer Frank Klein. The notice covers 35,558 shares to be sold through Morgan Stanley Smith Barney, with an indicated aggregate market value of $2,353,228.44. The issuer’s common shares outstanding are listed as 598,350,482 as of August 27, 2026. The filing also reports that Klein sold 45,692 shares on August 24, 2026 for $3,181,443.24, and 36,860 shares on May 28, 2026 for $5,433,997.04.
Rocket Lab Corp (RKLB) disclosed that Chief Financial Officer Adam C. Spice sold a total of 9,677 shares of common stock on August 24, 2026 in a series of open-market transactions. According to the disclosure, all sales were part of a sell-to-cover arrangement under a Rule 10b5-1 trading plan to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units. The reported weighted-average sale prices ranged from about $69.00 to $71.17 per share. Following these transactions, an indirect holding of 250,000 shares is reported as held by a trust.
Rocket Lab Corp (RKLB) disclosed that officer Agostino Ricupati, VP Corp Controller & CAO, reported three open‑market sales of common stock on 2026-08-24 totaling 669 shares. All transactions were designated as a sell-to-cover to satisfy tax withholding obligations from vesting restricted stock units previously granted to him.
The sales covered 619 shares at a weighted-average price of $69.5345, 20 shares at $70.2023, and 30 shares at $71.1700. Two of the trades were executed across multiple prices within disclosed ranges, and the filing does not state Ricupati’s share balance after these transactions.